Key Points We’re updating our forecast for AVAV post the firm’s 4QFY25 earnings call earlier this week. We’re maintaining our Overweight rating and raising our target price by USD117 to USD295. For...
Key Points Earnings revisions may have troughed with OLN shares in deep value terrain The transfer of acetyl market best practices to the chlor-alkali chain not being fully appreciated by the market,...
Key Points Production and onstream time continuing to show major progress Over 30 active trials underway. Successful commercialization news imminent, in our view We rate PCT shares Overweight with a USD18 per share...
Key Points We’re updating our forecast for NOC for the first time post 1Q as we lower our bottom-line outlook post the 1Q B-21 charge, and we maintain our Neutral rating....
Key Points We’re updating our forecast for LMT for the first time post 1Q and after management spoke at two recent investor conferences. We maintain our Neutral rating on the shares...
Key Points We’re raising our forecast for HEI post yesterday’s 2QFY25 earnings call and reiterating our Overweight rating on the shares despite the strong YTD performance. Our target price rises by USD38...
Key Points Share price decline overdone, valuation cheap, and debt levels manageable See company organically being able to pay down debt. If need be, asset sales could further accelerate debt paydown We rate...
Key Points We’re raising our forecast for WWD as we update for the first time post 2QFY25, and we’re also raising our target price. That said, we’re maintaining our Neutral rating...